Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Prostate Adenocarcinoma × Leuprolide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 48 Breast Neoplasms 8 Neoplasms 4 Leiomyoma 3 Breast Neoplasms, Male 2 Sexual Dysfunction, Physiological 1 Prostate Adenocarcinoma 1 Neoplasm Metastasis 1 Myofibroma 1 Breast Cancer Invasive 1 Advanced Prostate Cancer 1 Advanced Prostate Adenocarcinoma 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04914195 2023-08-01

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Bharat Serums and Vaccines Limited

Phase 3 Completed

Advanced Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡